Showing titles in Biotechnology

James D. Watson, the Nobel laureate whose pioneering work helped unlock the mystery of DNA's structure, charts the greatest scientific journey of our time, from the discovery of the double helix to today's controversies to what the future may hold. Updated to include new findings in gene editing, epigenetics, and agricultural chemistry as well as two entirely new chapters on personal genomics and cancer research. This is the most comprehensive and authoritative exploration of DNA's impact on our society and our world.

In 2010, scientists led by J. Craig Venter became the first to successfully create "synthetic life" - putting humankind at the threshold of the most important and exciting phase of biological research, one that will enable us to actually write the genetic code for designing new species to help us adapt and evolve for long-term survival. The science of synthetic genomics will have a profound impact on human existence, including chemical and energy generation, health, clean water and food production, environmental control, and possibly even our evolution.

Once, we humans could only observe evolution. Suddenly, we had conquered it. And yet, in Life as We Made It, evolutionary biologist Beth Shapiro argues that - despite how amazing our new technologies are - our ability to alter the course of evolution isn’t new. What is new is that where once we shaped evolution through brute force, we can now do it as artisans. That power comes not a moment too soon. If we are going to survive in the next few centuries, we must revise the book of life.

Millions of data enthusiasts from around the world compete on Kaggle, the most famous data science competition platform of them all. Participating in Kaggle competitions is a surefire way to improve your data analysis skills, network with an amazing community of data scientists, and gain valuable experience to help grow your career. The first audiobook of its kind, The Kaggle Book assembles in one place the techniques and skills you'll need for success in competitions, data science projects, and beyond. 

Few people know much about stem cell research beyond the ethical questions raised by using embryos. But in the last decade, stem cell research has made huge advances toward eliminating some of our most intractable diseases. Now this sweeping and accessible book introduces us to this cutting-edge science, which will revolutionize medicine and change the way we think about and treat disease.

This gripping narrative explores today's scientific pursuit of immortality, with exclusive visits inside Silicon Valley labs and interviews with the visionaries who believe we will soon crack into the aging process and cure death. We live in an age when billionaires are betting their fortunes on laboratory advances to prove aging unnecessary and death a disease that can be cured.

This audiobook, Tomorrow's Medicine, looks at some of the more fascinating areas where technology that could transform health is being developed, including cybernetics, regenerative medicine, nanotechnology, and genetically tailored treatments. Although many of these advances may not be ready to treat humans for many years, some of them may someday profoundly change - and extend - our lives. As exciting as the possibilities are to extend both the length and quality of life, immortality - or at least agelessness - may be forever out of our reach.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

Imagine living in a world where people use their computers, drive their cars, and communicate with one another simply by thinking. In this stunning and inspiring work, Duke University neuroscientist Miguel Nicolelis shares his revolutionary insights into how the brain creates thought and the human sense of self - and how this might be augmented by machines, so that the entire universe will be within our reach.

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them.

A lo largo del último siglo, la humanidad ha logrado lo imposible frenando la hambruna, la peste y la guerra. Por primera vez en la historia, más personas mueren por obesidad que por pasar hambre y hay más probabilidades de quitarse la vida que de morir en un conflicto bélico o un atentado terrorista.

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

Lee Hood did that rarest of things. He enabled scientists to see things they couldn't see before and do things they hadn't dreamed of doing. Scientists can now sequence complete human genomes in a day, setting in motion a revolution that is personalizing medicine. Hood, a son of the American West, was an unlikely candidate to transform biology. But with ferocious drive, he led a team at Caltech that developed the automated DNA sequencer, the tool that paved the way for the Human Genome Project.

Could extinct species, like mammoths and passenger pigeons, be brought back to life? The science says yes. In How to Clone a Mammoth, Beth Shapiro, evolutionary biologist and pioneer in "ancient DNA" research, walks listeners through the astonishing and controversial process of de-extinction.

Este é um audiolivro de agricultura para filósofos e um audiolivro de filosofia para agricultores. Como nenhum de nós pode se abster de pensar ou de comer, todos deveríamos ser filósofos e agricultores em alguma medida. Sintropia é a tendência expressa pela vida de acumular e organizar energia, ou seja, uma força complementar à entropia.

In the past two decades, GMOs have come to dominate the American diet. Advocates hail them as the future of food, an enhanced method of crop breeding that can help feed an ever-increasing global population and adapt to a rapidly changing environment. Critics, meanwhile, call for their banishment, insisting GMOs were designed by overeager scientists and greedy corporations to bolster an industrial food system that forces us to rely on cheap, unhealthy, processed food so they can turn an easy profit.

Can Biotechnology Abolish Suffering? is a collection of essays by utilitarian philosopher David Pearce. The essays deal with a variety of subjects, including the abolition of suffering through biotechnology, negative utilitarianism, our obligations toward non-human animals, the nature of consciousness, and the future of intelligent life.

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

Embark on an enlightening journey through the realm of regenerative medicine with 'Heal Smarter: 6 Key Questions for Regenerative Medicine Success.' This meticulously crafted book serves as a comprehensive guide to understanding Platelet-Rich Plasma (PRP) and stem cell therapies, two of the most promising frontiers in modern medical treatment.

This short book focuses on reasons why human cryopreservation and cryonics is ultimately desirable. This is done by examining specific reasons why utilizing cryonics may be beneficial, and also by examining potential objections to utilizing cryonics and why these are ultimately likely unfounded. Whether or not to try and utilize cryopreservation is ultimately a personal choice and this book attempts to help provide a way of making a more informed personal decision.